Article No
LS-C357868-20
NCBI Number | 4072 |
Application | ELISA, FC, IF, IHC, IP, WB |
Article No | LS-C357868-20 |
Country Availability | SE, FI, DK, NO, FO, GL |
Clone | 323/A3 |
Clone Type | monoclonal |
Concentration | 0.2 mg/ml |
Conjugation | Unconjugated |
Description | EPCAM antibody LS-C357868 is an unconjugated mouse monoclonal antibody to human EPCAM. Validated for ELISA, Flow, IF, IHC, IP and WB. |
Recommended Dilution | FC (0.5 - 1 ug/10e6 cells), IF (1 - 2 ug/ml), IHC-P (0.5 - 1 ug/ml), WB (0.25 - 0.5 ug/ml) |
Supplier | LifeSpan Biosciences |
Entrez Gene ID | 4072 |
Gene Symbol | EPCAM |
Immunogen | MCF-7 human breast cancer cells were used as the immunogen for this EpCAM antibody. |
Isotype | IgG1 k |
Notes | EPCAM antibody LS-C357868 is an unconjugated mouse monoclonal antibody to human EPCAM. Validated for ELISA, Flow, IF, IHC, IP and WB. |
Alias Names | EPCAM, 323/A3, ACSTD1, 17-1A, CD326, EGP, EGP34, Epithelial glycoprotein, GA733-2, HNPCC8, Ep-CAM, ESA, HEGP314, KS 1/4 antigen, KS1/4, KSA, M1S2, MIC18, MK-1, MH99, TROP1, TACST-1, TACSTD1, CD326 antigen, CO-17A, DIAR5, EGP-2, EGP314, EGP40, Epithelial glycoprotein 314, HEA125, Ly74, M4S1 |
Product Type | Antibodies Primary |
Protocol | Epithelial cellular adhesion molecule (EpCAM), is also identified as epithelial specific antigen (ESA) and the 40kDa transmembrane epithelial glycoprotein EGP40. EpCAM is expressed on the baso-lateral cell surface in most simple epithelia and a vast majority of carcinomas. This antibody has been used to distinguish adenocarcinoma from pleural mesothelioma and hepatocellular carcinoma. EpCAM antibody is also useful in distinguishing serous carcinomas of the ovary from mesothelioma. ELISA: Order BSA-free format for coating. |
Purification | Protein G Purified |
Shipping Information | RT |
Size | 20 µg |
Source / Host | mouse |
Species Reactivity | human |
Storage | 4°C |
Substrate / Buffer | PBS, pH 7.4, 0.1 mg/ml BSA, 0.05% Sodium Azide |
Technical Specifications | Human TACSTD1 / EPCAM |
Product Page Updated | 2024-04-12T09:20:06.597Z |